Table 3.
Influence of GPC-3 on key signaling pathways in HCC
| Signaling pathway | Role of GPC-3 | Mechanism | Impact on HCC | Key findings | References |
|---|---|---|---|---|---|
| Wnt signaling | ↑ autocrine/paracrine canonical Wnt signaling | ↑ Wnt concentration at receptor sites, facilitating Wnt-receptor interaction and stabilizing the Wnt-FZD complex | ↑HCC cell proliferation; associated with dysregulation in 95% of HCC cases |
GPC-3 acts as a bridge to stabilize Wnt and FZD through its HS chains; mutation in the Wnt-binding groove of GPC-3 reduces Wnt activation |
[15, 48, 52–57] |
| YAP signaling | Target gene of YAP; positive correlation with YAP activation | Downregulation of GPC-3 reduces YAP signaling; HN3 antibody targeting GPC-3 blocks YAP signaling | Promotes liver tumorigenesis and HCC progression | ↑YAP which plays a role in the recruitment of M2 macrophages | [58–62] |
| Growth factor signaling | Interacts with growth factors via HS chains | Facilitates signaling cascades by acting as a co-receptor; binds to growth factors, enhancing oncogenicity and cell migration | Stimulates cell growth, survival, and metastasis in HCC |
GPC-3 interaction with FGF, IGF, and HGF enhances signaling pathways like RAS-MAPK, PI3K-AKT ↑Cell migration ↑Invasion |
[63–71] |
GPC-3 Glypican 3, HCC hepatocellular carcinoma, Wnt wingless/Int-1, YAP Yes-associated protein, FGF fibroblast growth factor, IGF insulin-like growth factor, HGF hepatocyte growth factor, TGF-β2 transforming growth factor beta 2, HS heparan sulfate, FZD frizzled. Symbol: ↑increase